Company profile
AI for CAR-T | Coding.bio
coding.bio is accelerating CAR-T development through Machine Learning and Automation
Financial period: 1 Dec 2023 to 30 Nov 2024
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
1 Aug 2024 to 31 Jan 2026
Adoptive cell therapy is a treatment of patients using their own, modified immune cells. It involves harvesting T cells - the immune cells that normally recognise and eliminate pathogens - from the patient's blood, reprogramming them to identify cancer cells and re-introducing the newly modified cells back into the patient to destroy tumours. The modifyin...
1 Jun 2022 to 31 Oct 2023
Adoptive cell therapy is a treatment of patients using their own, modified immune cells. It involves harvesting T cells - the immune cells that normally recognise and eliminate pathogens - from the patient's blood, reprogramming them to recognise cancer cells and re-introducing the newly modified cells back into the patient to destroy tumours. The modifyi...
